In a reversal, chemical exports decline 4% past 2 years
India's chemical exports to North America dropped significantly, from 21% (between 2019 and 2021) to 2% (from 2021 to 2023), says McKinsey.
europe
March 2024
December 2023
November 2023
April 2023
May 2022
January 2021
December 2020
May 2020
April 2020
European firms to double Gen AI spending in 2024: Infosys
European companies will increase GenAI investments by 115% in the next year to $2.8 billion, says Infosys' research.
IT Firms: Mind The Bend
Demand slowdown has forced the big boys of Indian IT to cut their growth outlook for FY24. As macro uncertainty looms large, companies are shifting focus to controlling costs to protect profitability.
Pharma cos' revenue to grow 6-8% in FY24: ICRA
Revenue growth will be driven by steady performance across key markets — the U.S. and India — and some recovery in growth in the European market.
Brent crude hits $124 per barrel as EU agrees to ban 90% of Russian oil
The European Council agreed to immediately cut 75% of Russian oil imports.
Gold ruled 2020. Will it reign 2021 too?
Gold exchange traded funds added a record 877 tonnes during 2020, nearly 231 tonnes more than the 2009 record of 646 tonnes. Experts argue much of gold's growth drivers will continue in 2021 too.
St. Moritz: Where culture and adrenaline meet
St. Moritz is a village in the Engadin valley, in the Swiss Alps. A combination of top class sporting events, designer shopping, and breathtaking views make it the perfect winter holiday destination.
Covid-19: VC-backed healthtech deal values soar
Venture capital investment in healthtech hits $8.2 billion in the first quarter of 2020, the highest quarterly total on record, says Preqin; large deals continue to be made.
Covid-19 takes a toll on alternative assets outlook
Though investors are revising their commitments to alternatives in 2020, most are not adjusting their longer-term plans, says Preqin.
Markets are yet to bottom out
Analysts with varied views have the 2008 global financial meltdown as the nearest comparable to the Covid-19 pandemic. But they are agreed on one thing: the need for caution.
